Moreover, extracellular ATP released by tumor cells after chemotherapy can promote anti-tumor immunity via signaling through ATP-receptors P2RX7 on DCs, thereby activating the NLRP3 inflammasome, enhancing IL-1β secretion and boosting CD8+ T cell priming (99, 100). This evidence concerns the gene IL1B and neoplasm.